HIGH INCIDENCE OF RECEPTORS FOR LUTEINIZING HORMONE-RELEASING HORMONE (LHRH) AND LHRH RECEPTOR GENE EXPRESSION IN HUMAN PROSTATE CANCERS-Reference-Cited by-同舟云学术

HIGH INCIDENCE OF RECEPTORS FOR LUTEINIZING HORMONE-RELEASING HORMONE (LHRH) AND LHRH RECEPTOR GENE EXPRESSION IN HUMAN PROSTATE CANCERS

Published:2000-02 Issue:2 Volume:163 Page:623-629
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

HALMOS GABOR¹,ARENCIBIA JOSÉ M.¹,SCHALLY ANDREW V.¹,DAVIS RODNEY¹,BOSTWICK DAVID G.¹

Affiliation:

1. From the Endocrine, Polypeptide and Cancer Institute, Veterans Affairs Medical Center, and the Departments of Medicine and Urology, Tulane University School of Medicine, New Orleans, Louisiana; and the Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference35 articles.

1. Cancer statistics;Landis;CA Cancer J Clin,1998

2. Screening of prostate cancer - necessity or nonsense?;Schroeder;Eur J Cancer,1993

3. Studies on prostate cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate;Huggins;Cancer Res,1941

4. Treatment of advanced prostatic cancer;Sogani;Urol Clin North Am,1987

5. Hypothalamic and other peptide hormones;Schally,1997

Cited by 151 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging drugs for the treatment of benign prostatic hyperplasia: a 2023 update;Expert Opinion on Emerging Drugs;2024-06-14

2. Whole-Genome Comparative Copy Number Alteration Profiling between Malignant Pleural Mesothelioma and Asbestos-Induced Chronic Pleuritis;Journal of Environmental Pathology, Toxicology and Oncology;2024

3. RP215 and GHR106 Monoclonal Antibodies and Potential Therapeutic Applications;Open Journal of Immunology;2023

4. References;An Insider's Perspective of Prostate Cancer;2023

5. Synthesis, Radiolabeling, and Preclinical Evaluation of ⁶⁸Ga/¹⁷⁷Lu-Labeled Leuprolide Peptide Analog for the Detection of Breast Cancer;Cancer Biotherapy and Radiopharmaceuticals;2022-06-01